Laros-Van Gorkom, B.A.P.

patient study hemophilia von willebrand disease disease vwd patients hemophilic patients willebrand factor control level hr-qol center fviii difference score haemophilia carotid fi brinolysis netherland hemophilic university brachial population atherosclerosi health phenotype thromb treatment component summary domain brachial fmd table brinolysi subject femoral imt plasma signi thrombosis femoral brinolytic artery quartile effect risk factors blood type 3 vwd severity von willebrand factor non-obese summary fi brinolytic fviii levels plasma fi brinolytic haemost quality component activity role limitations association presence haemostasi limitation society clt +pci gender plaque assay hemophilia patients tendency measurement signi ficantly status van der bom clot lysis time thrombin result leiden university risk factor 0.001